HEADER CELL ADHESION 12-SEP-06 2ICA TITLE CD11A (LFA1) I-DOMAIN COMPLEXED WITH BMS-587101 AKA 5-[(5S, 9R)-9-(4- TITLE 2 CYANOPHENYL)-3-(3,5-DICHLOROPHENYL)-1-METHYL-2,4-DIOXO-1,3,7- TITLE 3 TRIAZASPIRO [4.4]NON-7-YL]METHYL]-3-THIOPHENECARBOXYLICACID COMPND MOL_ID: 1; COMPND 2 MOLECULE: INTEGRIN ALPHA-L; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: VWFA DOMAIN, RESIDUES 154-332; COMPND 5 SYNONYM: LEUKOCYTE ADHESION GLYCOPROTEIN LFA-1 ALPHA CHAIN, LFA-1A, COMPND 6 LEUKOCYTE FUNCTION-ASSOCIATED MOLECULE 1 ALPHA CHAIN, CD11A ANTIGEN; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: ITGAL, CD11A; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PET28A; SOURCE 11 OTHER_DETAILS: MINIMAL MEDIA KEYWDS INHIBITOR, PROTEIN-LIGAND COMPLEX, CELL ADHESION EXPDTA X-RAY DIFFRACTION AUTHOR S.SHERIFF,H.EINSPAHR REVDAT 4 30-AUG-23 2ICA 1 REMARK SEQADV REVDAT 3 18-OCT-17 2ICA 1 REMARK REVDAT 2 24-FEB-09 2ICA 1 VERSN REVDAT 1 19-DEC-06 2ICA 0 JRNL AUTH D.POTIN,M.LAUNAY,F.MONATLIK,P.MALABRE,M.FABREGUETTES, JRNL AUTH 2 A.FOUQUET,M.MAILLET,E.NICOLAI,L.DORGERET,F.CHEVALLIER, JRNL AUTH 3 D.BESSE,M.DUFORT,F.CAUSSADE,S.Z.AHMAD,D.K.STETSKO,S.SKALA, JRNL AUTH 4 P.M.DAVIS,P.BALIMANE,K.PATEL,Z.YANG,P.MARATHE,J.POSTELNECK, JRNL AUTH 5 R.M.TOWNSEND,V.GOLDFARB,S.SHERIFF,H.EINSPAHR,K.KISH, JRNL AUTH 6 M.F.MALLEY,J.D.DIMARCO,J.Z.GOUGOUTAS,P.KADIYALA,D.L.CHENEY, JRNL AUTH 7 R.W.TEJWANI,D.K.MURPHY,K.W.MCINTYRE,X.YANG,S.CHAO,L.LEITH, JRNL AUTH 8 Z.XIAO,A.MATHUR,B.C.CHEN,D.R.WU,S.C.TRAEGER,M.MCKINNON, JRNL AUTH 9 J.C.BARRISH,J.A.ROBL,E.J.IWANOWICZ,S.J.SUCHARD,T.G.DHAR JRNL TITL DISCOVERY AND DEVELOPMENT OF 5-[(5S,9R)-9- JRNL TITL 2 (4-CYANOPHENYL)-3-(3,5-DICHLOROPHENYL)-1- JRNL TITL 3 METHYL-2,4-DIOXO-1,3,7-TRIAZASPIRO[4.4]NON- JRNL TITL 4 7-YL-METHYL]-3-THIOPHENECARBOXYLIC ACID (BMS-587101)-A SMALL JRNL TITL 5 MOLECULE ANTAGONIST LEUKOCYTE FUNCTION ASSOCIATED ANTIGEN-1. JRNL REF J.MED.CHEM. V. 49 6946 2006 JRNL REFN ISSN 0022-2623 JRNL PMID 17125246 JRNL DOI 10.1021/JM0610806 REMARK 2 REMARK 2 RESOLUTION. 1.56 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.56 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 34.01 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 1021678.820 REMARK 3 DATA CUTOFF LOW (ABS(F)) : 0.0000 REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 98.2 REMARK 3 NUMBER OF REFLECTIONS : 23387 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.192 REMARK 3 R VALUE (WORKING SET) : 0.191 REMARK 3 FREE R VALUE : 0.223 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.800 REMARK 3 FREE R VALUE TEST SET COUNT : 1364 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.006 REMARK 3 REMARK 3 FIT/AGREEMENT OF MODEL WITH ALL DATA. REMARK 3 R VALUE (WORKING + TEST SET, NO CUTOFF) : 0.1920 REMARK 3 R VALUE (WORKING SET, NO CUTOFF) : 0.1910 REMARK 3 FREE R VALUE (NO CUTOFF) : 0.223 REMARK 3 FREE R VALUE TEST SET SIZE (%, NO CUTOFF) : 5.800 REMARK 3 FREE R VALUE TEST SET COUNT (NO CUTOFF) : 1364 REMARK 3 ESTIMATED ERROR OF FREE R VALUE (NO CUTOFF) : 0.0060 REMARK 3 TOTAL NUMBER OF REFLECTIONS (NO CUTOFF) : 23387 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 8 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.56 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.63 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 87.40 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 2428 REMARK 3 BIN R VALUE (WORKING SET) : 0.3090 REMARK 3 BIN FREE R VALUE : 0.3380 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 5.60 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 143 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.028 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 1414 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 37 REMARK 3 SOLVENT ATOMS : 144 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 16.60 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 15.70 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -1.34000 REMARK 3 B22 (A**2) : 1.43000 REMARK 3 B33 (A**2) : -0.09000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.17 REMARK 3 ESD FROM SIGMAA (A) : 0.06 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.20 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.03 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.004 REMARK 3 BOND ANGLES (DEGREES) : 1.200 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 24.00 REMARK 3 IMPROPER ANGLES (DEGREES) : 0.640 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 1.070 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 1.650 ; 2.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 1.950 ; 2.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 2.840 ; 2.500 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : FLAT MODEL REMARK 3 KSOL : 0.38 REMARK 3 BSOL : 48.33 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PAR REMARK 3 PARAMETER FILE 2 : WATER_REP.PAR REMARK 3 PARAMETER FILE 3 : ION.PARAM REMARK 3 PARAMETER FILE 4 : 2IC.PAR REMARK 3 PARAMETER FILE 5 : NULL REMARK 3 TOPOLOGY FILE 1 : PROTEIN.TOP REMARK 3 TOPOLOGY FILE 2 : WATER.TOP REMARK 3 TOPOLOGY FILE 3 : ION.TOP REMARK 3 TOPOLOGY FILE 4 : 2IC.TOP REMARK 3 TOPOLOGY FILE 5 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2ICA COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 19-SEP-06. REMARK 100 THE DEPOSITION ID IS D_1000039405. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 01-MAY-02 REMARK 200 TEMPERATURE (KELVIN) : 100.0 REMARK 200 PH : 8.9 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU RU200 REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : "BLUE" CONFOCAL REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : RIGAKU REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 23466 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.560 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.5 REMARK 200 DATA REDUNDANCY : 4.000 REMARK 200 R MERGE (I) : 0.04100 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 35.6000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.56 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.62 REMARK 200 COMPLETENESS FOR SHELL (%) : 86.3 REMARK 200 DATA REDUNDANCY IN SHELL : 2.50 REMARK 200 R MERGE FOR SHELL (I) : 0.23700 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 4.600 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: PDB ENTRY 1LFA CHAIN A REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 38.94 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.01 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 80% (W/V) SODIUM CITRATE, 5% (V/V) REMARK 280 GLYCEROL, MEASURED PH 8.9, VAPOR DIFFUSION, HANGING DROP, REMARK 280 TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 20.15000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 31.65000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 31.70000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 31.65000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 20.15000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 31.70000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 125 REMARK 465 SER A 126 REMARK 465 HIS A 127 REMARK 465 TYR A 307 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 MET A 128 CG SD CE REMARK 470 ASN A 163 CG OD1 ND2 REMARK 470 ASP A 229 CG OD1 OD2 REMARK 470 LYS A 268 CG CD CE NZ REMARK 470 GLU A 269 CG CD OE1 OE2 REMARK 470 ASP A 290 CG OD1 OD2 REMARK 470 GLU A 293 CG CD OE1 OE2 REMARK 470 GLU A 301 CG CD OE1 OE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 SER A 174 -102.64 -147.10 REMARK 500 LEU A 204 -131.37 -124.82 REMARK 500 ASP A 244 -159.29 -103.63 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 2IC A 1 DBREF 2ICA A 129 307 UNP P20701 ITAL_HUMAN 154 332 SEQADV 2ICA GLY A 125 UNP P20701 CLONING ARTIFACT SEQADV 2ICA SER A 126 UNP P20701 CLONING ARTIFACT SEQADV 2ICA HIS A 127 UNP P20701 CLONING ARTIFACT SEQADV 2ICA MET A 128 UNP P20701 CLONING ARTIFACT SEQRES 1 A 183 GLY SER HIS MET ASN VAL ASP LEU VAL PHE LEU PHE ASP SEQRES 2 A 183 GLY SER MET SER LEU GLN PRO ASP GLU PHE GLN LYS ILE SEQRES 3 A 183 LEU ASP PHE MET LYS ASP VAL MET LYS LYS LEU SER ASN SEQRES 4 A 183 THR SER TYR GLN PHE ALA ALA VAL GLN PHE SER THR SER SEQRES 5 A 183 TYR LYS THR GLU PHE ASP PHE SER ASP TYR VAL LYS ARG SEQRES 6 A 183 LYS ASP PRO ASP ALA LEU LEU LYS HIS VAL LYS HIS MET SEQRES 7 A 183 LEU LEU LEU THR ASN THR PHE GLY ALA ILE ASN TYR VAL SEQRES 8 A 183 ALA THR GLU VAL PHE ARG GLU GLU LEU GLY ALA ARG PRO SEQRES 9 A 183 ASP ALA THR LYS VAL LEU ILE ILE ILE THR ASP GLY GLU SEQRES 10 A 183 ALA THR ASP SER GLY ASN ILE ASP ALA ALA LYS ASP ILE SEQRES 11 A 183 ILE ARG TYR ILE ILE GLY ILE GLY LYS HIS PHE GLN THR SEQRES 12 A 183 LYS GLU SER GLN GLU THR LEU HIS LYS PHE ALA SER LYS SEQRES 13 A 183 PRO ALA SER GLU PHE VAL LYS ILE LEU ASP THR PHE GLU SEQRES 14 A 183 LYS LEU LYS ASP LEU PHE THR GLU LEU GLN LYS LYS ILE SEQRES 15 A 183 TYR HET 2IC A 1 37 HETNAM 2IC 5-[(5S,9R)-9-(4-CYANOPHENYL)-3-(3,5-DICHLOROPHENYL)-1- HETNAM 2 2IC METHYL-2,4-DIOXO-1,3,7-TRIAZASPIRO [4.4]NON-7- HETNAM 3 2IC YL]METHYL]-3-THIOPHENECARBOXYLICACID FORMUL 2 2IC C26 H20 CL2 N4 O4 S FORMUL 3 HOH *144(H2 O) HELIX 1 1 GLN A 143 LEU A 161 1 19 HELIX 2 2 ASP A 182 LYS A 190 1 9 HELIX 3 3 ASP A 191 LYS A 197 1 7 HELIX 4 4 ASN A 207 VAL A 219 1 13 HELIX 5 5 ARG A 221 GLY A 225 5 5 HELIX 6 6 ILE A 248 LYS A 252 5 5 HELIX 7 7 LYS A 263 GLN A 266 5 4 HELIX 8 8 THR A 267 THR A 273 1 7 HELIX 9 9 LEU A 274 ALA A 278 5 5 HELIX 10 10 PRO A 281 PHE A 285 1 5 SHEET 1 A 6 TYR A 177 PHE A 181 0 SHEET 2 A 6 TYR A 166 PHE A 173 -1 N GLN A 172 O LYS A 178 SHEET 3 A 6 VAL A 130 ASP A 137 1 N PHE A 134 O VAL A 171 SHEET 4 A 6 THR A 231 THR A 238 1 O ILE A 235 N VAL A 133 SHEET 5 A 6 ILE A 255 ILE A 261 1 O ILE A 259 N ILE A 236 SHEET 6 A 6 VAL A 286 LEU A 289 1 O LYS A 160 N GLY A 260 CISPEP 1 LYS A 280 PRO A 281 0 1.63 SITE 1 AC1 11 TYR A 166 VAL A 233 ILE A 235 ILE A 255 SITE 2 AC1 11 TYR A 257 ILE A 259 LYS A 287 LEU A 302 SITE 3 AC1 11 ILE A 306 HOH A 324 HOH A 381 CRYST1 40.300 63.400 63.300 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.024814 0.000000 0.000000 0.00000 SCALE2 0.000000 0.015773 0.000000 0.00000 SCALE3 0.000000 0.000000 0.015798 0.00000